Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
strategic review
Biotech
4 strange cash-saving efforts biotechs are using to stay afloat
Biotech has always been a little unconventional, but, as the industry’s bear market drags on, efforts to stay afloat are reaching a whole new level.
Gabrielle Masson
,
Darren Incorvaia
Jun 20, 2025 6:00am
Keros culls phase 2 PAH program, 70 staff roles
May 29, 2025 10:10am
Leap halves head count amid 'difficult market environment'
May 13, 2025 9:10am
Charles River launches strategic review, shakes up board
May 7, 2025 11:14am
Pliant cuts workforce by 45% after bexotegrast trial safety woes
May 2, 2025 7:33am
George Church spinout restructures, considers strategic options
Mar 13, 2025 2:00pm